Last10K.com

Medicure Inc (MCUJF) SEC Filing 20-F Annual report for the fiscal year ending Tuesday, December 31, 2019

SEC Filings

MCUJF Annual Reports

    20-F Annual Report April 2022
    20-F Annual Report April 2021
  • 20-F Annual Report April 2020
  • 20-F Annual Report April 2019
    20-F Annual Report May 2018
    20-F Annual Report April 2017
    20-F Annual Report March 2016
    20-F Annual Report April 2015
    20-F Annual Report September 2014

Medicure Inc

CIK: 1133519 Ticker: MCUJF

View differences made from one year to another to evaluate Medicure Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Medicure Inc.

Continue

Assess how Medicure Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Medicure Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Cover
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Financial Position
Consolidated Statements Of Net (Loss) Income And Comprehensive (Loss) Income
Accounts Receivable
Accounts Receivable (Detail Textuals)
Accounts Receivable (Details)
Accounts Receivable (Tables)
Basis Of Preparation Of Financial Statements
Capital Stock
Capital Stock (Detail Textuals 1)
Capital Stock (Detail Textuals 2)
Capital Stock (Detail Textuals 3)
Capital Stock (Detail Textuals)
Capital Stock (Details 1)
Capital Stock (Details 2)
Capital Stock (Details 3)
Capital Stock (Details 4)
Capital Stock (Details 6)
Capital Stock (Details 7)
Capital Stock (Details)
Capital Stock (Tables)
Commitments And Contingencies
Commitments And Contingencies (Detail Textuals 1)
Commitments And Contingencies (Detail Textuals)
Commitments And Contingencies (Details)
Commitments And Contingencies (Tables)
Determination Of Fair Values
Discontinued Operations
Discontinued Operations (Detail Textuals)
Discontinued Operations (Details 1)
Discontinued Operations (Details)
Discontinued Operations (Tables)
Expenses By Nature
Expenses By Nature (Details)
Expenses By Nature (Tables)
Finance Income (Expense)
Finance Income (Expense) (Details 1)
Finance Income (Expense) (Details)
Finance Income (Expense) (Tables)
Financial Instruments
Financial Instruments (Detail Textuals)
Financial Instruments (Details 1)
Financial Instruments (Details 2)
Financial Instruments (Details)
Financial Instruments (Tables)
Holdback Receivable
Holdback Receivable (Detail Textuals)
Income Taxes
Income Taxes (Detail Textuals 1)
Income Taxes (Detail Textuals)
Income Taxes (Details 1)
Income Taxes (Details 2)
Income Taxes (Details 3)
Income Taxes (Details)
Income Taxes (Tables)
Intangible Assets
Intangible Assets (Detail Textuals)
Intangible Assets (Details)
Intangible Assets (Tables)
Inventories
Inventories (Detail Textuals)
Inventories (Details)
Inventories (Tables)
Investment In Sensible Medical
Investment In Sensible Medical (Detail Textuals)
New Standards And Interpretations
New Standards And Interpretations (Detail Textuals)
New Standards And Interpretations (Details 1)
New Standards And Interpretations (Details)
New Standards And Interpretations (Tables)
Property, Plant And Equipment
Property, Plant And Equipment (Detail Textuals)
Property, Plant And Equipment (Details)
Property, Plant And Equipment (Tables)
Related Party Transactions
Related Party Transactions (Detail Textuals 1)
Related Party Transactions (Detail Textuals 2)
Related Party Transactions (Detail Textuals 3)
Related Party Transactions (Detail Textuals)
Related Party Transactions (Details)
Related Party Transactions (Tables)
Reporting Entity
Royalty Obligation
Royalty Obligation (Detail Textuals)
Segmented Information
Segmented Information (Detail Textuals 1)
Segmented Information (Detail Textuals)
Segmented Information (Details)
Segmented Information (Tables)
Significant Accounting Policies
Significant Accounting Policies (Details)
Significant Accounting Policies (Policies)
Significant Accounting Policies (Tables)
Subsequent Events
Ticker: MCUJF
CIK: 1133519
Form Type: 20-F Annual Report
Accession Number: 0001193125-20-108359
Submitted to the SEC: Wed Apr 15 2020 8:27:59 PM EST
Accepted by the SEC: Thu Apr 16 2020
Period: Tuesday, December 31, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/mcujf/0001193125-20-108359.htm